Increase in demand for analytical services in pharmaceuticals is a prominent factor driving the global pharmaceutical testing and analytical services market growth. Bioanalytical testing helps check if a drug is in working condition or subject to any adverse effects.
It also helps ascertain whether or not the prescribed formulation should be continued. Speedy approval process of clinical trials and new drugs by regulatory bodies is also expediting the market for drug analysis services.
Companies operating in the global pharmaceutical testing and analytical services market are adopting the smart quality approach to integrate quality control in manufacture and development of pharmaceuticals.
Labs are likely to achieve productivity enhancement by 150% to 200% of their existing rates by adhering to smart quality control, as shorter testing time and improved agility are capable of reducing lead times by 60% to 70%.
Analytical services play a vital role with respect to safety, quality, and efficacy of pharmaceutical products throughout the development lifecycle, from early stages of development to manufacturing at the commercial scale.
Pharmacological testing refers to non-human tests in laboratories. The results are then shared with regulatory bodies such as the U.S. FDA to determine if the treatment is safe to be experimented with human volunteers.
Governments of several countries across the globe are taking initiatives to strengthen their analytical testing capabilities.
For instance, the Government of China recently issued notification regarding upgrade of the quality of generic drugs, elimination of the backlog of drug applications, improvement in quality of approval and review, and encouragement of extensive research to suffice the requirement of medicines at the global level.
However, drug testing specimens are likely to be tampered through adulteration or dilution. Furthermore, the process of sample collection can be time-consuming. These factors are projected to restrain the pharmaceutical testing and analytical services market dynamics and future analysis to a certain extent.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Increase in the frequency of pharmaceutical testing methods, emphasis on core competencies of pharmaceuticals, and emergence of outsourcing of pharmaceuticals are driving the need for pharmaceutical analytical testing.
In July 2021, LGM Pharma announced that it had introduced analytics services offerings to provide analytical testing as well as stability services to the pharmaceutical sector.
Advanced pharmaceutical analytical testing solutions comprise real-time product quality control rendered by biopharmaceutical companies to differentiate between biosimilars and biologics.
Key participants use advanced equipment such as High-Resolution Accurate Mass Spectrometry (HRAM) instrument, fully validated laboratory information & management systems (LIMS), morphologically directed Raman spectroscopy (MDRS), and harmonized data acquisition applications software to provide efficient outsourcing services.
Pharmaceutical companies prefer outsourcing their analytical testing programs at an earlier stage of the product development lifecycle in order to concentrate on their core therapeutics strengths.
Thus, pharmaceutical quality control is the epicenter of the pharmaceutical testing and analytical services industry.
Speedy approval of drugs and clinical trials worldwide is driving the demand for advanced pharmaceutical analytical testing solutions. For instance, the U.S. FDA approved 50 new therapeutics in 2021, which gives the five-year average as 51 drugs per year.
In April 2022, the WHO confirmed that almost 349 vaccines were being developed. Eurofins Scientific extended support to the testing of Ad26.COV2.S. It was Johnson & Johnson’s investigational Covid-19 vaccine candidate.
Drugs that are forwarded to regulatory bodies are categorized as new molecular entities (NMEs) under New Drug Applications (NDAs) and novel therapeutic biologics under Biologics License Applications (BLA).
Clinical trials are also being registered at a faster pace. For instance, as per Clinicaltrial.gov 2022 update, 433,207 studies were registered in 2020; of these, 31% are registered in the U.S.
Thus, rise in number of approvals of drugs and clinical trials is augmenting the pharmaceutical testing and analytical services market.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
North America accounted for the largest pharmaceutical testing and analytical services market share in 2022. The region is projected to maintain its dominant position during the forecast period.
According to the Center for Drug Evaluation and Research (CDER), 50 drugs were approved in the U.S. alone in 2021. High product approval in the U.S. is augmenting market progress in North America.
Establishment of several pharmaceutical and biopharmaceutical companies in Europe and Asia Pacific is bolstering the demand for pharmaceutical quality control analysis in these regions. WHO-cGMP compliance facilities are propagating pharma outsourcing trends.
Companies in pharmaceutical testing and analytical services industry are engaged in new product launches as well as indirect modes of expansion such as mergers & acquisitions to strengthen their market position.
In March 2022, Transgene presented a poster displaying a promising preliminary Phase I data regarding TG4050, its exclusive Neoantigen cancer vaccine, at the American Association for Cancer Research (AACR) annual meeting 2022
In November 2021, Eurofins announced that it had acquired Modern Testing Service with the objective of leading the testing, inspection, and certification (TIC) industry for consumer products.
The market report profiles leading players such as Eurofins Scientific, Laboratory Corporation of America Holdings, Charles river Laboratories International, Inc., SGS S.A., Intertek Group plc, RD laboratories, Inc., Wuxi AppTec Co., Ltd., DYNALABS LLC (Infinity Laboratories), and ARL Bio Pharma based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 8.3 Bn |
| Market Forecast (Value) in 2034 | US$ 19.7 Bn |
| Growth Rate (CAGR) | 8.0% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 8.3 Bn in 2023
It is projected to grow at a CAGR of 8.0% from 2024 to 2034
Rise in demand for analytical testing services and increase in number of approvals of clinical trials and drugs
The medical device companies segment accounted for the largest share in 2022
North America was the dominant region in 2023
Eurofins Scientific, Laboratory Corporation of America Holdings, Charles River Laboratories International, Inc., SGS S.A., Intertek Group plc, RD laboratories, Inc., Wuxi AppTec Co., Ltd., DYNALABS LLC (Infinity Laboratories), and ARL Bio Pharma
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pharmaceutical Testing and Analytical Services Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pharmaceutical Testing and Analytical Services Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Pharmaceutical Testing and Analytical Services Market Analysis and Forecast, by Service Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Service Type, 2020-2034
6.3.1. Bioanalytical Testing
6.3.1.1. Cell-based Assays
6.3.1.2. Virology Testing
6.3.1.3. Others
6.3.2. Method Development & Validation
6.3.2.1. Extractables & Leachables Method Development and Validation
6.3.2.2. Stability-indicating Method Validation
6.3.2.3. Process Impurity Method Development & Validation
6.3.2.4. Others
6.3.3. Raw Material Testing
6.3.3.1. Heavy Metal Testing
6.3.3.2. Complete Compendial Testing
6.3.3.3. Others
6.3.4. Stability Testing
6.3.4.1. Drug Substance Stability Testing
6.3.4.2. Formulation Evaluation Stability Testing
6.3.4.3. Others
6.3.5. Microbial Testing
6.3.5.1. Microbial Limit Testing
6.3.5.2. Sterility Testing
6.3.5.3. Endotoxin Testing
6.3.5.4. Others
6.3.6. Others
6.4. Market Attractiveness Analysis, by Service Type
7. Global Pharmaceutical Testing and Analytical Services Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2020-2034
7.3.1. Medical Device Companies
7.3.2. Pharmaceutical & Biopharmaceutical Companies
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Pharmaceutical Testing and Analytical Services Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2020-2034
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Pharmaceutical Testing and Analytical Services Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Service Type, 2020-2034
9.3.1. Bioanalytical Testing
9.3.1.1. Cell-based Assays
9.3.1.2. Virology Testing
9.3.1.3. Others
9.3.2. Method Development & Validation
9.3.2.1. Extractables & Leachables Method Development and Validation
9.3.2.2. Stability-indicating Method Validation
9.3.2.3. Process Impurity Method Development & Validation
9.3.2.4. Others
9.3.3. Raw Material Testing
9.3.3.1. Heavy Metal Testing
9.3.3.2. Complete Compendial Testing
9.3.3.3. Others
9.3.4. Stability Testing
9.3.4.1. Drug Substance Stability Testing
9.3.4.2. Formulation Evaluation Stability Testing
9.3.4.3. Others
9.3.5. Microbial Testing
9.3.5.1. Microbial Limit Testing
9.3.5.2. Sterility Testing
9.3.5.3. Endotoxin Testing
9.3.5.4. Others
9.3.6. Others
9.4. Market Value Forecast, by End-user, 2020-2034
9.4.1. Medical Device Companies
9.4.2. Pharmaceutical & Biopharmaceutical Companies
9.4.3. Others
9.5. Market Value Forecast, by Country, 2020-2034
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Service Type
9.6.2. By End-user
9.6.3. By Country
10. Europe Pharmaceutical Testing and Analytical Services Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Service Type, 2020-2034
10.3.1. Bioanalytical Testing
10.3.1.1. Cell-based Assays
10.3.1.2. Virology Testing
10.3.1.3. Others
10.3.2. Method Development & Validation
10.3.2.1. Extractables & Leachables Method Development and Validation
10.3.2.2. Stability-indicating Method Validation
10.3.2.3. Process Impurity Method Development & Validation
10.3.2.4. Others
10.3.3. Raw Material Testing
10.3.3.1. Heavy Metal Testing
10.3.3.2. Complete Compendial Testing
10.3.3.3. Others
10.3.4. Stability Testing
10.3.4.1. Drug Substance Stability Testing
10.3.4.2. Formulation Evaluation Stability Testing
10.3.4.3. Others
10.3.5. Microbial Testing
10.3.5.1. Microbial Limit Testing
10.3.5.2. Sterility Testing
10.3.5.3. Endotoxin Testing
10.3.5.4. Others
10.3.6. Others
10.4. Market Value Forecast, by End-user, 2020-2034
10.4.1. Medical Device Companies
10.4.2. Pharmaceutical & Biopharmaceutical Companies
10.4.3. Others
10.5. Market Value Forecast, by Country/Sub-region, 2020-2034
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Service Type
10.6.2. By End-user
10.6.3. By Country/Sub-region
11. Asia Pacific Pharmaceutical Testing and Analytical Services Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Service Type, 2020-2034
11.3.1. Bioanalytical Testing
11.3.1.1. Cell-based Assays
11.3.1.2. Virology Testing
11.3.1.3. Others
11.3.2. Method Development & Validation
11.3.2.1. Extractables & Leachables Method Development and Validation
11.3.2.2. Stability-indicating Method Validation
11.3.2.3. Process Impurity Method Development & Validation
11.3.2.4. Others
11.3.3. Raw Material Testing
11.3.3.1. Heavy Metal Testing
11.3.3.2. Complete Compendial Testing
11.3.3.3. Others
11.3.4. Stability Testing
11.3.4.1. Drug Substance Stability Testing
11.3.4.2. Formulation Evaluation Stability Testing
11.3.4.3. Others
11.3.5. Microbial Testing
11.3.5.1. Microbial Limit Testing
11.3.5.2. Sterility Testing
11.3.5.3. Endotoxin Testing
11.3.5.4. Others
11.3.6. Others
11.4. Market Value Forecast, by End-user, 2020-2034
11.4.1. Medical Device Companies
11.4.2. Pharmaceutical & Biopharmaceutical Companies
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Service Type
11.6.2. By End-user
11.6.3. By Country/Sub-region
12. Latin America Pharmaceutical Testing and Analytical Services Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Service Type, 2020-2034
12.3.1. Bioanalytical Testing
12.3.1.1. Cell-based Assays
12.3.1.2. Virology Testing
12.3.1.3. Others
12.3.2. Method Development & Validation
12.3.2.1. Extractables & Leachables Method Development and Validation
12.3.2.2. Stability-indicating Method Validation
12.3.2.3. Process Impurity Method Development & Validation
12.3.2.4. Others
12.3.3. Raw Material Testing
12.3.3.1. Heavy Metal Testing
12.3.3.2. Complete Compendial Testing
12.3.3.3. Others
12.3.4. Stability Testing
12.3.4.1. Drug Substance Stability Testing
12.3.4.2. Formulation Evaluation Stability Testing
12.3.4.3. Others
12.3.5. Microbial Testing
12.3.5.1. Microbial Limit Testing
12.3.5.2. Sterility Testing
12.3.5.3. Endotoxin Testing
12.3.5.4. Others
12.3.6. Others
12.4. Market Value Forecast, by End-user, 2020-2034
12.4.1. Medical Device Companies
12.4.2. Pharmaceutical & Biopharmaceutical Companies
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Service Type
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Service Type, 2020-2034
13.3.1. Bioanalytical Testing
13.3.1.1. Cell-based Assays
13.3.1.2. Virology Testing
13.3.1.3. Others
13.3.2. Method Development & Validation
13.3.2.1. Extractables & Leachables Method Development and Validation
13.3.2.2. Stability-indicating Method Validation
13.3.2.3. Process Impurity Method Development & Validation
13.3.2.4. Others
13.3.3. Raw Material Testing
13.3.3.1. Heavy Metal Testing
13.3.3.2. Complete Compendial Testing
13.3.3.3. Others
13.3.4. Stability Testing
13.3.4.1. Drug Substance Stability Testing
13.3.4.2. Formulation Evaluation Stability Testing
13.3.4.3. Others
13.3.5. Microbial Testing
13.3.5.1. Microbial Limit Testing
13.3.5.2. Sterility Testing
13.3.5.3. Endotoxin Testing
13.3.5.4. Others
13.3.6. Others
13.4. Market Value Forecast, by End-user, 2020-2034
13.4.1. Medical Device Companies
13.4.2. Pharmaceutical & Biopharmaceutical Companies
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Service Type
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2023)
14.3. Company Profiles
14.3.1. Eurofins Scientific
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Laboratory Corporation of America Holdings
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Charles River Laboratories International, Inc.
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. SGS S.A.
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Intertek Group plc
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. RD laboratories, Inc.
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. Wuxi AppTec Co., Ltd.
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. DYNALABS LLC (Infinity Laboratories)
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. ARL Bio Pharma
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview
List of Tables
Table 01: Global Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Service Type, 2020-2034
Table 02: Global Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 03: Global Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 04: North America Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 05: North America Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Service Type, 2020-2034
Table 06: North America Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 07: Europe Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 08: Europe Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Service Type, 2020-2034
Table 09: Europe Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 10: Asia Pacific Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 11: Asia Pacific Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Service Type, 2020-2034
Table 12: Asia Pacific Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Latin America Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Latin America Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Service Type, 2020-2034
Table 15: Latin America Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 16: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 17: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by Service Type, 2020-2034
Table 18: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Pharmaceutical Testing and Analytical Services Market Revenue (US$ Mn), by Service Type, 2023
Figure 03: Global Pharmaceutical Testing and Analytical Services Market Value Share, by Service Type, 2023
Figure 04: Global Pharmaceutical Testing and Analytical Services Market Revenue (US$ Mn), by End-user, 2023
Figure 05: Global Pharmaceutical Testing and Analytical Services Market Value Share, by End-user, 2023
Figure 06: Global Pharmaceutical Testing and Analytical Services Market Value Share, by Region, 2023
Figure 07: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, 2020-2034
Figure 08: Global Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2023 and 2034
Figure 09: Global Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Service Type, 2020-2034
Figure 10: Global Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2023 and 2034
Figure 11: Global Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by End-user, 2020-2034
Figure 12: Global Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Region, 2023 and 2034
Figure 13: Global Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Region, 2020-2034
Figure 14: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 15: North America Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Country, 2020-2034
Figure 16: North America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Country, 2023 and 2034
Figure 17: North America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2023 and 2034
Figure 18: North America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2023 and 2034
Figure 19: North America Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Service Type, 2020-2034
Figure 20: North America Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by End-user, 2020-2034
Figure 21: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 22: Europe Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
Figure 23: Europe Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 24: Europe Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2023 and 2034
Figure 25: Europe Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2023 and 2034
Figure 26: Europe Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Service Type, 2020-2034
Figure 27: Europe Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by End-user, 2020-2034
Figure 28: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 29: Asia Pacific Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
Figure 30: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 31: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2023 and 2034
Figure 32: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Asia Pacific Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Service Type, 2020-2034
Figure 34: Asia Pacific Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by End-user, 2020-2034
Figure 35: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 36: Latin America Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
Figure 37: Latin America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 38: Latin America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2023 and 2034
Figure 39: Latin America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2023 and 2034
Figure 40: Latin America Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Service Type, 2020-2034
Figure 41: Latin America Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by End-user, 2020-2034
Figure 42: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 43: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
Figure 44: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 45: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2023 and 2034
Figure 46: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2023 and 2034
Figure 47: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Service Type, 2020-2034
Figure 48: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by End-user, 2020-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Pharmaceutical Testing and Analytical Services Market
